Shikeagi Kato, an endocrinology researcher who resigned from the University of Tokyo in March 2012 amid an investigation that concluded 43 of his papers should be retracted, has retracted five more papers.
The newest is in this week’s Nature, for “GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis,” a paper first published in 2009. Here’s the notice: Continue reading Shigeaki Kato notches five more retractions, including one in Nature
Here’s a retraction that leaves us itching to know more:
The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.
Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is:
Continue reading “Personal rivalry” leads to retraction of nut-health paper
Talk about a Trojan Horse.
Biochemical and Biophysical Research Communications has withdrawn a paper it published earlier this year on metabolic proteins linked to diabetes, not because the article was bogus but because the authors appear to have been. The work itself is accurate — indeed, it likely belongs to a Harvard scientist, Bruce Spiegelman, who’d presented his data on the subject several times recently and was in the process of preparing his results for publication. We’ve written about researchers trying to punk journals with faked articles, and about a researcher who apparently made up a co-author, but here’s something new!
Nature has the story. According to Nature, in July Spiegelman: Continue reading Journal withdraws diabetes paper written by apparently bogus authors
The author of a review article on diabetes has been forced to retract the paper after it emerged that he failed to properly credit some of the text — an omission we generally associate with the word plagiarism.
The article, “Colonic flora, probiotics, obesity and diabetes,” was written by Paul Marik, of Eastern Virginia Medical School, and appeared in July 2012 in Frontiers in Endocrinology. It has been cited once, according to Thomson Scientific’s Web of Knowledge.
Here’s the retraction notice:
Continue reading Frontiers papers on GMO debate, diabetes retracted for improperly cited text
So how long do researchers have to keep records of experiments?
We had that question while reading the retraction notice for a 2007 paper in the Journal of Clinical Investigation: Continue reading JCI paper retracted for duplicated panels after authors can’t provide original data
The Aging Male (the journal, not the demographic) is retracting a 2013 paper by a group of Chinese researchers who’d published the same work — more or less — in a Chinese title.
The article, “Testosterone therapy improves psychological distress and health-related quality of life in Chinese men with symptomatic late-onset hypogonadism patients,” came from a group at Peking University People’s Hospital, in Beijing.
But as the retraction notice explains: Continue reading Don’t feel so bad, The Aging Male: It happens to lots of journals
Regulatory Peptides is retracting a 2010 paper by a group of five authors in China and one in Texas — and the presence of that last one was the problem.
The article, “Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice,” had as its last (dare we say, senior) author Susan T. Howard, a mycobacterium expert at the University of Texas Health Science Center in Tyler. Trouble was, Howard disavowed any role in the paper.
According to the retraction notice: Continue reading One-too-many authors scuttles paper on mouse metabolism
The Journal of Endocrinology has run a correction for a paper by Rui Curi, the Brazilian scientist whose lawyers threatened Science-Fraud.org after the site ran a number of posts critical of Curi’s work.
Here’s the notice for “Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress”: Continue reading Another correction for Rui Curi, whose legal threats helped force shutdown of Science Fraud site
An endocrinologist who resigned from the University of Tokyo last March as the university was investigating his work has retracted another paper.
Here’s the notice for the paper by corresponding author Shigeaki Kato and colleagues in the Journal of Bone and Mineral Research: Continue reading Shigeaki Kato notches fifth retraction
A group of neuroscientists has retracted a paper published earlier this last year in Diabetes after realizing that a figure that took up a whole page of the paper may not have been quite right.
Here’s the notice for “Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy”: Continue reading Authors retract Diabetes paper after submitting it “without knowledge of inherent errors”